LOHYPTO

Serial Number 99112441
681

Registration Progress

Application Filed
Mar 31, 2025
Under Examination
Approved for Publication
Published for Opposition
Jan 6, 2026
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Feb 24, 2026 58 days

Trademark Image

LOHYPTO

Basic Information

Serial Number
99112441
Filing Date
March 31, 2025
Published for Opposition
January 6, 2026
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Dec 18, 2025
Application
Pending
Classes
005

Rights Holder

Mineralys Therapeutics, Inc.

03
Address
150 N. Radnor Chester Road, Suite F200
Radnor, PA 19087

Ownership History

Mineralys Therapeutics, Inc.

Original Applicant
03
Radnor, PA

Legal Representation

Attorney
Holly Pekowsky

USPTO Deadlines

Next Deadline
58 days remaining
Final Refusal E-Mailed
Due Date
February 24, 2026
Extension Available
Until May 24, 2026

Application History

17 events
Date Code Type Description Documents
Dec 10, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 8, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 8, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 8, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Nov 24, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 24, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 24, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 31, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 31, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 31, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 28, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 28, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 28, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 31, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 31, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of hypertension, sleep apnea, chronic kidney disease, heart failure, primary aldosteronism, myocardial infarction, coronary artery disease, blood vessel wall thickening, renal fibrosis, nephropathy, and vascular dementia

Classification

International Classes
005